Europe Peripheral Artery Disease Market Size, Share & Trends Analysis Report By Product Type (Drugs, and Devices), By End User (Hospitals, and Specialty Clinics), By Country and Growth Forecast, 2024 - 2031
Published Date : 10-Aug-2024 |
Pages: 141 |
Formats: PDF |
COVID-19 Impact on the Europe Peripheral Artery Disease Market
Market Overview
The Europe Peripheral Artery Disease Market would witness market growth of 6.5% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Peripheral Artery Disease Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $480.3 million by 2031. The UK market is exhibiting a CAGR of 5.7% during (2024 - 2031). Additionally, The France market would experience a CAGR of 7.4% during (2024 - 2031).
The diagnosis and treatment of peripheral arterial disease have been significantly improved as a result of technological breakthroughs in medical equipment and minimally invasive treatments, which has further contributed to the expansion of the market. Innovations like drug-eluting stents, atherectomy devices, and advanced imaging technologies like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have revolutionized PAD management. These technologies enable precise diagnosis, targeted treatment, and improved patient outcomes.
However, despite these advancements, the market faces several challenges hamper its growth. One of the primary barriers is the high cost associated with advanced treatments and technologies. The financial burden on healthcare systems can also limit the widespread adoption of these advanced therapies, impeding market growth. Limited access to advanced healthcare facilities and technologies in certain regions poses a significant challenge. The availability of advanced diagnostic instruments and treatment options for PAD may be limited by disparities in healthcare infrastructure between developed and developing countries and between urban and rural areas.
There is a major element that is driving the increased need for PAD therapy in France, and that is the rising prevalence of hypertension and diabetes. According to the International Diabetes Federation, approximately 3.9 million people in the country were living with diabetes as of 2021. The French healthcare system has implemented national screening programs and public health campaigns to reduce smoking rates and promote healthy lifestyles. PAD is effectively managed by prioritizing early diagnosis and advanced treatment options, as emphasized by the Ministry of Health. Hence, the European market presents a promising outlook.
Free Valuable Insights: The Global Peripheral Artery Disease Market will Hit USD 7.1 Billion by 2031, at a CAGR of 6.9%
Based on Product Type, the market is segmented into Drugs (Antiplatelet Medicines, Statins, Anti Hypertensive Medication, and Others), and Devices (Peripheral Stents, Peripheral Angioplasty Balloons, Peripheral Catheters, Plaque Modification Devices, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, and Peripheral Accessories). Based on End User, the market is segmented into Hospitals, and Specialty Clinics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Becton, Dickinson and Company
- Bayer AG
- Koninklijke Philips N.V.
- Abbott Laboratories
- Terumo Corporation
- B.Braun Melsungen AG
- Medtronic PLC
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Biotronik SE & Co. KG
Europe Peripheral Artery Disease Market Report Segmentation
By Product Type
- Drugs
- Antiplatelet Medicines
- Statins
- Anti Hypertensive Medication
- Others
- Devices
- Peripheral Stents
- Peripheral Angioplasty Balloons
- Peripheral Catheters
- Plaque Modification Devices
- Inferior Vena Cava Filters
- Hemodynamic Flow Alteration Devices
- Peripheral Accessories
By End User
- Hospitals
- Specialty Clinics
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Peripheral Artery Disease Market, by Product Type
1.4.2 Europe Peripheral Artery Disease Market, by End User
1.4.3 Europe Peripheral Artery Disease Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Peripheral Artery Disease Market by Product Type
4.1 Europe Drugs Market by Country
4.2 Europe Peripheral Artery Disease Market by Drugs Type
4.2.1 Europe Antiplatelet Medicines Market by Country
4.2.2 Europe Statins Market by Country
4.2.3 Europe Anti Hypertensive Medication Market by Country
4.2.4 Europe Others Market by Country
4.3 Europe Devices Market by Country
4.4 Europe Peripheral Artery Disease Market by Devices Type
4.4.1 Europe Peripheral Stents Market by Country
4.4.2 Europe Peripheral Angioplasty Balloons Market by Country
4.4.3 Europe Peripheral Catheters Market by Country
4.4.4 Europe Plaque Modification Devices Market by Country
4.4.5 Europe Inferior Vena Cava Filters Market by Country
4.4.6 Europe Hemodynamic Flow Alteration Devices Market by Country
4.4.7 Europe Peripheral Accessories Market by Country
Chapter 5. Europe Peripheral Artery Disease Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Specialty Clinics Market by Country
Chapter 6. Europe Peripheral Artery Disease Market by Country
6.1 Germany Peripheral Artery Disease Market
6.1.1 Germany Peripheral Artery Disease Market by Product Type
6.1.1.1 Germany Peripheral Artery Disease Market by Drugs Type
6.1.1.2 Germany Peripheral Artery Disease Market by Devices Type
6.1.2 Germany Peripheral Artery Disease Market by End User
6.2 UK Peripheral Artery Disease Market
6.2.1 UK Peripheral Artery Disease Market by Product Type
6.2.1.1 UK Peripheral Artery Disease Market by Drugs Type
6.2.1.2 UK Peripheral Artery Disease Market by Devices Type
6.2.2 UK Peripheral Artery Disease Market by End User
6.3 France Peripheral Artery Disease Market
6.3.1 France Peripheral Artery Disease Market by Product Type
6.3.1.1 France Peripheral Artery Disease Market by Drugs Type
6.3.1.2 France Peripheral Artery Disease Market by Devices Type
6.3.2 France Peripheral Artery Disease Market by End User
6.4 Russia Peripheral Artery Disease Market
6.4.1 Russia Peripheral Artery Disease Market by Product Type
6.4.1.1 Russia Peripheral Artery Disease Market by Drugs Type
6.4.1.2 Russia Peripheral Artery Disease Market by Devices Type
6.4.2 Russia Peripheral Artery Disease Market by End User
6.5 Spain Peripheral Artery Disease Market
6.5.1 Spain Peripheral Artery Disease Market by Product Type
6.5.1.1 Spain Peripheral Artery Disease Market by Drugs Type
6.5.1.2 Spain Peripheral Artery Disease Market by Devices Type
6.5.2 Spain Peripheral Artery Disease Market by End User
6.6 Italy Peripheral Artery Disease Market
6.6.1 Italy Peripheral Artery Disease Market by Product Type
6.6.1.1 Italy Peripheral Artery Disease Market by Drugs Type
6.6.1.2 Italy Peripheral Artery Disease Market by Devices Type
6.6.2 Italy Peripheral Artery Disease Market by End User
6.7 Rest of Europe Peripheral Artery Disease Market
6.7.1 Rest of Europe Peripheral Artery Disease Market by Product Type
6.7.1.1 Rest of Europe Peripheral Artery Disease Market by Drugs Type
6.7.1.2 Rest of Europe Peripheral Artery Disease Market by Devices Type
6.7.2 Rest of Europe Peripheral Artery Disease Market by End User
Chapter 7. Company Profiles
7.1 Becton, Dickinson, and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Koninklijke Philips N.V.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.3.6 SWOT Analysis
7.4 Abbott Laboratories
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and Mergers:
7.7.6 SWOT Analysis
7.8 Boston Scientific Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 SWOT Analysis
7.10. Biotronik SE & Co. KG
7.10.1 Company Overview
7.10.2 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Peripheral Artery Disease Market, by Product Type
1.4.2 Europe Peripheral Artery Disease Market, by End User
1.4.3 Europe Peripheral Artery Disease Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Peripheral Artery Disease Market by Product Type
4.1 Europe Drugs Market by Country
4.2 Europe Peripheral Artery Disease Market by Drugs Type
4.2.1 Europe Antiplatelet Medicines Market by Country
4.2.2 Europe Statins Market by Country
4.2.3 Europe Anti Hypertensive Medication Market by Country
4.2.4 Europe Others Market by Country
4.3 Europe Devices Market by Country
4.4 Europe Peripheral Artery Disease Market by Devices Type
4.4.1 Europe Peripheral Stents Market by Country
4.4.2 Europe Peripheral Angioplasty Balloons Market by Country
4.4.3 Europe Peripheral Catheters Market by Country
4.4.4 Europe Plaque Modification Devices Market by Country
4.4.5 Europe Inferior Vena Cava Filters Market by Country
4.4.6 Europe Hemodynamic Flow Alteration Devices Market by Country
4.4.7 Europe Peripheral Accessories Market by Country
Chapter 5. Europe Peripheral Artery Disease Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Specialty Clinics Market by Country
Chapter 6. Europe Peripheral Artery Disease Market by Country
6.1 Germany Peripheral Artery Disease Market
6.1.1 Germany Peripheral Artery Disease Market by Product Type
6.1.1.1 Germany Peripheral Artery Disease Market by Drugs Type
6.1.1.2 Germany Peripheral Artery Disease Market by Devices Type
6.1.2 Germany Peripheral Artery Disease Market by End User
6.2 UK Peripheral Artery Disease Market
6.2.1 UK Peripheral Artery Disease Market by Product Type
6.2.1.1 UK Peripheral Artery Disease Market by Drugs Type
6.2.1.2 UK Peripheral Artery Disease Market by Devices Type
6.2.2 UK Peripheral Artery Disease Market by End User
6.3 France Peripheral Artery Disease Market
6.3.1 France Peripheral Artery Disease Market by Product Type
6.3.1.1 France Peripheral Artery Disease Market by Drugs Type
6.3.1.2 France Peripheral Artery Disease Market by Devices Type
6.3.2 France Peripheral Artery Disease Market by End User
6.4 Russia Peripheral Artery Disease Market
6.4.1 Russia Peripheral Artery Disease Market by Product Type
6.4.1.1 Russia Peripheral Artery Disease Market by Drugs Type
6.4.1.2 Russia Peripheral Artery Disease Market by Devices Type
6.4.2 Russia Peripheral Artery Disease Market by End User
6.5 Spain Peripheral Artery Disease Market
6.5.1 Spain Peripheral Artery Disease Market by Product Type
6.5.1.1 Spain Peripheral Artery Disease Market by Drugs Type
6.5.1.2 Spain Peripheral Artery Disease Market by Devices Type
6.5.2 Spain Peripheral Artery Disease Market by End User
6.6 Italy Peripheral Artery Disease Market
6.6.1 Italy Peripheral Artery Disease Market by Product Type
6.6.1.1 Italy Peripheral Artery Disease Market by Drugs Type
6.6.1.2 Italy Peripheral Artery Disease Market by Devices Type
6.6.2 Italy Peripheral Artery Disease Market by End User
6.7 Rest of Europe Peripheral Artery Disease Market
6.7.1 Rest of Europe Peripheral Artery Disease Market by Product Type
6.7.1.1 Rest of Europe Peripheral Artery Disease Market by Drugs Type
6.7.1.2 Rest of Europe Peripheral Artery Disease Market by Devices Type
6.7.2 Rest of Europe Peripheral Artery Disease Market by End User
Chapter 7. Company Profiles
7.1 Becton, Dickinson, and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Koninklijke Philips N.V.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.3.6 SWOT Analysis
7.4 Abbott Laboratories
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.4.6 SWOT Analysis
7.5 Terumo Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and Mergers:
7.7.6 SWOT Analysis
7.8 Boston Scientific Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 SWOT Analysis
7.10. Biotronik SE & Co. KG
7.10.1 Company Overview
7.10.2 SWOT Analysis
List of Tables
TABLE 1 Europe Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 2 Europe Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 3 Europe Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 4 Europe Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 5 Europe Drugs Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Drugs Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 8 Europe Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 9 Europe Antiplatelet Medicines Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Antiplatelet Medicines Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Statins Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe Statins Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe Anti Hypertensive Medication Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Anti Hypertensive Medication Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Devices Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Devices Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 20 Europe Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 21 Europe Peripheral Stents Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Peripheral Stents Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Peripheral Angioplasty Balloons Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Peripheral Angioplasty Balloons Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Peripheral Catheters Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Peripheral Catheters Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Plaque Modification Devices Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Plaque Modification Devices Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Inferior Vena Cava Filters Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Inferior Vena Cava Filters Market by Country, 2024 - 2031, USD Million
TABLE 31 Europe Hemodynamic Flow Alteration Devices Market by Country, 2020 - 2023, USD Million
TABLE 32 Europe Hemodynamic Flow Alteration Devices Market by Country, 2024 - 2031, USD Million
TABLE 33 Europe Peripheral Accessories Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe Peripheral Accessories Market by Country, 2024 - 2031, USD Million
TABLE 35 Europe Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 36 Europe Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 37 Europe Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 38 Europe Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 39 Europe Specialty Clinics Market by Country, 2020 - 2023, USD Million
TABLE 40 Europe Specialty Clinics Market by Country, 2024 - 2031, USD Million
TABLE 41 Europe Peripheral Artery Disease Market by Country, 2020 - 2023, USD Million
TABLE 42 Europe Peripheral Artery Disease Market by Country, 2024 - 2031, USD Million
TABLE 43 Germany Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 44 Germany Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 45 Germany Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 46 Germany Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 47 Germany Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 48 Germany Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 49 Germany Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 50 Germany Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 51 Germany Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 52 Germany Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 53 UK Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 54 UK Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 55 UK Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 56 UK Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 57 UK Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 58 UK Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 59 UK Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 60 UK Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 61 UK Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 62 UK Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 63 France Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 64 France Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 65 France Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 66 France Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 67 France Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 68 France Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 69 France Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 70 France Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 71 France Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 72 France Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 73 Russia Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 74 Russia Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 75 Russia Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 76 Russia Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 77 Russia Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 78 Russia Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 79 Russia Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 80 Russia Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 81 Russia Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 82 Russia Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 83 Spain Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 84 Spain Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 85 Spain Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 86 Spain Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 87 Spain Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 88 Spain Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 89 Spain Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 90 Spain Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 91 Spain Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 92 Spain Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 93 Italy Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 94 Italy Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 95 Italy Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 96 Italy Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 97 Italy Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 98 Italy Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 99 Italy Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 100 Italy Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 101 Italy Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 102 Italy Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 103 Rest of Europe Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 104 Rest of Europe Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 105 Rest of Europe Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 106 Rest of Europe Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 107 Rest of Europe Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 108 Rest of Europe Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 109 Rest of Europe Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 110 Rest of Europe Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 111 Rest of Europe Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 112 Rest of Europe Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 113 Key Information – Becton, Dickinson and Company
TABLE 114 Key Information – Bayer AG
TABLE 115 Key Information – Koninklijke Philips N.V.
TABLE 116 Key Information – Abbott Laboratories
TABLE 117 Key Information – Terumo Corporation
TABLE 118 Key Information – B. Braun Melsungen AG
TABLE 119 Key Information – Medtronic PLC
TABLE 120 Key Information – Boston Scientific Corporation
TABLE 121 key information – Cardinal Health, Inc.
TABLE 122 Key Information – Biotronik SE & Co. KG
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Peripheral Artery Disease Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Peripheral Artery Disease Market
FIG 4 Porter’s Five Forces Analysis – Peripheral Artery Disease Market
FIG 5 Europe Peripheral Artery Disease Market share by Product Type, 2023
FIG 6 Europe Peripheral Artery Disease Market share by Product Type, 2031
FIG 7 Europe Peripheral Artery Disease Market by Product Type, 2020 - 2031, USD Million
FIG 8 Europe Peripheral Artery Disease Market share by End User, 2023
FIG 9 Europe Peripheral Artery Disease Market share by End User, 2031
FIG 10 Europe Peripheral Artery Disease Market by End User, 2020 - 2031, USD Million
FIG 11 Europe Peripheral Artery Disease Market share by Country, 2023
FIG 12 Europe Peripheral Artery Disease Market share by Country, 2031
FIG 13 Europe Peripheral Artery Disease Market by Country, 2020 - 2031, USD Million
FIG 14 SWOT Analysis: Becton, Dickinson and company
FIG 15 Swot Analysis: Bayer AG
FIG 16 SWOT Analysis: Koninklijke Philips N.V.
FIG 17 SWOT Analysis: Abbott Laboratories
FIG 18 SWOT Analysis: Terumo Corporation
FIG 19 SWOT Analysis: B. Braun Melsungen AG
FIG 20 SWOT Analysis: Medtronic PLC
FIG 21 SWOT Analysis: Boston Scientific Corporation
FIG 22 Swot Analysis: Cardinal Health, Inc.
FIG 23 SWOT Analysis: Biotronik SE & Co. KG
TABLE 2 Europe Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 3 Europe Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 4 Europe Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 5 Europe Drugs Market by Country, 2020 - 2023, USD Million
TABLE 6 Europe Drugs Market by Country, 2024 - 2031, USD Million
TABLE 7 Europe Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 8 Europe Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 9 Europe Antiplatelet Medicines Market by Country, 2020 - 2023, USD Million
TABLE 10 Europe Antiplatelet Medicines Market by Country, 2024 - 2031, USD Million
TABLE 11 Europe Statins Market by Country, 2020 - 2023, USD Million
TABLE 12 Europe Statins Market by Country, 2024 - 2031, USD Million
TABLE 13 Europe Anti Hypertensive Medication Market by Country, 2020 - 2023, USD Million
TABLE 14 Europe Anti Hypertensive Medication Market by Country, 2024 - 2031, USD Million
TABLE 15 Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 16 Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 17 Europe Devices Market by Country, 2020 - 2023, USD Million
TABLE 18 Europe Devices Market by Country, 2024 - 2031, USD Million
TABLE 19 Europe Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 20 Europe Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 21 Europe Peripheral Stents Market by Country, 2020 - 2023, USD Million
TABLE 22 Europe Peripheral Stents Market by Country, 2024 - 2031, USD Million
TABLE 23 Europe Peripheral Angioplasty Balloons Market by Country, 2020 - 2023, USD Million
TABLE 24 Europe Peripheral Angioplasty Balloons Market by Country, 2024 - 2031, USD Million
TABLE 25 Europe Peripheral Catheters Market by Country, 2020 - 2023, USD Million
TABLE 26 Europe Peripheral Catheters Market by Country, 2024 - 2031, USD Million
TABLE 27 Europe Plaque Modification Devices Market by Country, 2020 - 2023, USD Million
TABLE 28 Europe Plaque Modification Devices Market by Country, 2024 - 2031, USD Million
TABLE 29 Europe Inferior Vena Cava Filters Market by Country, 2020 - 2023, USD Million
TABLE 30 Europe Inferior Vena Cava Filters Market by Country, 2024 - 2031, USD Million
TABLE 31 Europe Hemodynamic Flow Alteration Devices Market by Country, 2020 - 2023, USD Million
TABLE 32 Europe Hemodynamic Flow Alteration Devices Market by Country, 2024 - 2031, USD Million
TABLE 33 Europe Peripheral Accessories Market by Country, 2020 - 2023, USD Million
TABLE 34 Europe Peripheral Accessories Market by Country, 2024 - 2031, USD Million
TABLE 35 Europe Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 36 Europe Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 37 Europe Hospitals Market by Country, 2020 - 2023, USD Million
TABLE 38 Europe Hospitals Market by Country, 2024 - 2031, USD Million
TABLE 39 Europe Specialty Clinics Market by Country, 2020 - 2023, USD Million
TABLE 40 Europe Specialty Clinics Market by Country, 2024 - 2031, USD Million
TABLE 41 Europe Peripheral Artery Disease Market by Country, 2020 - 2023, USD Million
TABLE 42 Europe Peripheral Artery Disease Market by Country, 2024 - 2031, USD Million
TABLE 43 Germany Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 44 Germany Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 45 Germany Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 46 Germany Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 47 Germany Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 48 Germany Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 49 Germany Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 50 Germany Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 51 Germany Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 52 Germany Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 53 UK Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 54 UK Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 55 UK Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 56 UK Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 57 UK Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 58 UK Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 59 UK Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 60 UK Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 61 UK Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 62 UK Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 63 France Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 64 France Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 65 France Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 66 France Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 67 France Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 68 France Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 69 France Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 70 France Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 71 France Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 72 France Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 73 Russia Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 74 Russia Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 75 Russia Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 76 Russia Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 77 Russia Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 78 Russia Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 79 Russia Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 80 Russia Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 81 Russia Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 82 Russia Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 83 Spain Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 84 Spain Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 85 Spain Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 86 Spain Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 87 Spain Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 88 Spain Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 89 Spain Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 90 Spain Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 91 Spain Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 92 Spain Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 93 Italy Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 94 Italy Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 95 Italy Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 96 Italy Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 97 Italy Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 98 Italy Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 99 Italy Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 100 Italy Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 101 Italy Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 102 Italy Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 103 Rest of Europe Peripheral Artery Disease Market, 2020 - 2023, USD Million
TABLE 104 Rest of Europe Peripheral Artery Disease Market, 2024 - 2031, USD Million
TABLE 105 Rest of Europe Peripheral Artery Disease Market by Product Type, 2020 - 2023, USD Million
TABLE 106 Rest of Europe Peripheral Artery Disease Market by Product Type, 2024 - 2031, USD Million
TABLE 107 Rest of Europe Peripheral Artery Disease Market by Drugs Type, 2020 - 2023, USD Million
TABLE 108 Rest of Europe Peripheral Artery Disease Market by Drugs Type, 2024 - 2031, USD Million
TABLE 109 Rest of Europe Peripheral Artery Disease Market by Devices Type, 2020 - 2023, USD Million
TABLE 110 Rest of Europe Peripheral Artery Disease Market by Devices Type, 2024 - 2031, USD Million
TABLE 111 Rest of Europe Peripheral Artery Disease Market by End User, 2020 - 2023, USD Million
TABLE 112 Rest of Europe Peripheral Artery Disease Market by End User, 2024 - 2031, USD Million
TABLE 113 Key Information – Becton, Dickinson and Company
TABLE 114 Key Information – Bayer AG
TABLE 115 Key Information – Koninklijke Philips N.V.
TABLE 116 Key Information – Abbott Laboratories
TABLE 117 Key Information – Terumo Corporation
TABLE 118 Key Information – B. Braun Melsungen AG
TABLE 119 Key Information – Medtronic PLC
TABLE 120 Key Information – Boston Scientific Corporation
TABLE 121 key information – Cardinal Health, Inc.
TABLE 122 Key Information – Biotronik SE & Co. KG
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Peripheral Artery Disease Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Peripheral Artery Disease Market
FIG 4 Porter’s Five Forces Analysis – Peripheral Artery Disease Market
FIG 5 Europe Peripheral Artery Disease Market share by Product Type, 2023
FIG 6 Europe Peripheral Artery Disease Market share by Product Type, 2031
FIG 7 Europe Peripheral Artery Disease Market by Product Type, 2020 - 2031, USD Million
FIG 8 Europe Peripheral Artery Disease Market share by End User, 2023
FIG 9 Europe Peripheral Artery Disease Market share by End User, 2031
FIG 10 Europe Peripheral Artery Disease Market by End User, 2020 - 2031, USD Million
FIG 11 Europe Peripheral Artery Disease Market share by Country, 2023
FIG 12 Europe Peripheral Artery Disease Market share by Country, 2031
FIG 13 Europe Peripheral Artery Disease Market by Country, 2020 - 2031, USD Million
FIG 14 SWOT Analysis: Becton, Dickinson and company
FIG 15 Swot Analysis: Bayer AG
FIG 16 SWOT Analysis: Koninklijke Philips N.V.
FIG 17 SWOT Analysis: Abbott Laboratories
FIG 18 SWOT Analysis: Terumo Corporation
FIG 19 SWOT Analysis: B. Braun Melsungen AG
FIG 20 SWOT Analysis: Medtronic PLC
FIG 21 SWOT Analysis: Boston Scientific Corporation
FIG 22 Swot Analysis: Cardinal Health, Inc.
FIG 23 SWOT Analysis: Biotronik SE & Co. KG